MORE than half (53 per cent) of men in Jamaica have been experiencing varying levels of depression during the post-COVID-19 period, according to a study conducted by Northern Caribbean University .
A brain region known as the amygdala could play a key role in predicting symptom improvement following ketamine therapy in patients with treatment-resistant anxious depression, according to new research published in the Journal of Affective Disorders. .